Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
CRISPR THERAP N (NQ: CRSP)
62.63 USD  +3.32 (+5.60%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,793,590
Open 59.42
Bid (Size) 61.54 (300)
Ask (Size) 62.70 (100)
Prev. Close 59.31
Today's Range 59.31 - 62.93
52wk Range 14.32 - 73.90
Shares Outstanding 46,842,969
Dividend Yield N/A
Performance
YTD
+148.83%
+148.83%
1 Month
-3.05%
-3.05%
3 Month
+21.56%
+21.56%
6 Month
+214.09%
+214.09%
1 Year
+323.46%
+323.46%
Top News
More News
CRISPR Therapeutics to Participate in Three June Conferences
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team... Read More
from GlobeNewswire News Releases
Biotech Stocks Crispr, Editas, Intellia Fall On Gene-Editing Study
Shares in biotech stocks Crispr Therapeutics, Editas Medicine and Intellia Therapeutics fell after a scientific publication reported that gene-editing techniques might cause cancer. Read More
from Investor's Business Daily
More News
Read More
Intellia Confirms Crispr Risk Irrelevant To Its Program, With No Adjustments Needed
category NTLA , Thomas Barnes , Interview , and 8 more.
from Benzinga
Interesting CRSP Put And Call Options For July 27th
category Stocks
from Market News Video
Is Gene Editing Dangerous? 4 Things You Should Know
category CRSP , SGMO , EDIT , and 2 more.
from Motley Fool
Should CRISPR Stock Investors Worry About Cancer?
category EDIT , CRSP , REGN , and 3 more.
from Motley Fool
CRISPR-related stocks sink after report that gene-editing technology might cause cancer
category Health/Care , IBB , Pharmaceuticals , and 7 more.
from MarketWatch
Crispr Therapeutics Falls As Studies Suggest Possible Cancerous Side Effect
category Top Stories , Sam Kulkarni , Nature Medicine , and 13 more.
from Benzinga
CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic
category CRSP , EDIT , Market News , and 1 more.
from Motley Fool
CRISPR stocks tank after research shows edited cells might cause cancer
category Intellia Therapeutics Inc , Medical biotechnology industry , Editas Medicine Inc , and 10 more.
from CNBC.com News
Here's Why CRISPR Stocks are Getting Rocked Today
category EDIT , CRSP , NTLA , and 1 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.